ACE and dementia: Experimental studies suggest that treatments targeting this pathway, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), may have beneficial effects against the development or progression of cognitive decline and dementia [7].